Albert Labs Appoints Mackie Research As Lead Agent For Private Placement Of Proceeds Up To $4 Million Pre-RTO

Albert Labs leverages Real-World Evidence (RWE) studies across Europe to accelerate access to its proprietary psilocybin-based therapy for patients with urgent, unmet needs. April 14TH , 2021 – VANCOUVER, BRITISH COLUMBIA, Vancouver, British Columbia – Albert Labs Inc. (“Albert Labs” or the “Company“) is pleased to announce a brokered private placement (the “Brokered Offering”) of up to 16,000…

Source